Correlation Between Palisade Bio and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Palisade Bio and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Cardio Diagnostics.
Diversification Opportunities for Palisade Bio and Cardio Diagnostics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Palisade and Cardio is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Palisade Bio i.e., Palisade Bio and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Palisade Bio and Cardio Diagnostics
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Cardio Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Palisade Bio is 2.42 times less risky than Cardio Diagnostics. The stock trades about -0.24 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 30.00 in Cardio Diagnostics Holdings on September 13, 2024 and sell it today you would earn a total of 122.00 from holding Cardio Diagnostics Holdings or generate 406.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Palisade Bio vs. Cardio Diagnostics Holdings
Performance |
Timeline |
Palisade Bio |
Cardio Diagnostics |
Palisade Bio and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Palisade Bio and Cardio Diagnostics
The main advantage of trading using opposite Palisade Bio and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |